BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1733-1737

  Liu, Bo ^a   Li, Da ^a   Guan, Yi Fu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer 1; Insulin like growth factor 1 receptor; Ovarian cancer

Indexed keywords

BISULFITE; BRCA1 PROTEIN; LENTIVIRUS VECTOR; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LENTIVIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

EID: 84896285539     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1929     Document Type: Article

References (20)

1. Lech A, Daneva T, Pashova S, et al: Ovarian cancer as a genetic disease. Front Biosci (Landmark Ed) 18: 543-563, 2013.
2. Pruthi S, Gostout BS and Lindor NM: Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer. Mayo Clin Proc 85: 1111-1120, 2010.
3. Werner H and Bruchim I: IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol 13: e537-e544, 2012.
4. Samani AA, Yakar S, LeRoith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47, 2007.
5. Bruchim I and Werner H: Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets 17: 307-320, 2013.
6. Pfäffle R, Kiess W and Klammt J: Downstream insulin-like growth factor. Endocr Dev 23: 42-51, 2012.
7. Scully R: Histological Typing of Ovarian Tumours. Vol 9. 2nd edition. Springer, Berlin, Germany, 1999.
8. Bi FF, Li D and Yang Q: Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer. BMC Cancer 13: 90, 2013.
9. Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F and Balkwill FR: Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther 5: 382-390, 2006.
10. Varley KE, Gertz J, Bowling KM, et al: Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res 23: 555-567, 2013.
11. Hudelist G, Wagner T, Rosner M, et al: Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer 14: 1053-1062, 2007.
12. Maor S, Yosepovich A, Papa MZ, Yarden RI, Mayer D, Friedman E and Werner H: Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. Cancer Lett 257: 236-243, 2007.
13. Chen X, Meng Q, Zhao Y, et al: Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett 328: 318-324, 2013.
14. Calvo V and Beato M: BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. Cancer Res 71: 3422-3431, 2011.
15. Katiyar P, Ma Y, Riegel A, Fan S and Rosen EM: Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Mol Endocrinol 23: 1135-1146, 2009.
16. Ansquer Y, Legrand A, Bringuier AF, Vadrot N, Lardeux B, Mandelbrot L and Feldmann G: Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line. Anticancer Res 25: 243-248, 2005.
17. Ma Y, Fan S, Hu C, et al: BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol 24: 76-90, 2010.
18. Ma Y, Hu C, Riegel AT, Fan S and Rosen EM: Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity. Mol Endocrinol 21: 1905-1923, 2007.
19. Ingle JN, Liu M, Wickerham DL, et al: Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. Cancer Discov 3: 812-825, 2013.
20. Nelson AC, Lyons TR, Young CD, Hansen KC, Anderson SM and Holt JT: AKT regulates BRCA1 stability in response to hormone signaling. Mol Cell Endocrinol 319: 129-142, 2010.